Chronic Kidney Disease Registry Platform Study

Trial Identifier: D1843R00355
Sponsor: AstraZeneca
Start Date: November 2023
Primary Completion Date: November 2028
Study Completion Date: November 2028
Condition: Chronic Kidney Diseases

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China Baotou, China
China Beijing, China
China Changsha, China
China Changzhou, China
China Chengdu, China
China Chongqing, China
China Dongguan, China
China Guangzhou, China
China Haikou, China
China Hefei, China
China Hengyang, China
China Huaian, China
China Jilin, China
China Jining, China
China Nanchang, China
China Nanjing, China
China Nanning, China
China Ningbo, China
China Panjin, China
China Pingxiang, China
China Shanghai, China
China Shantou, China
China Shenzhen, China
China Taizhou, China
China Wenzhou, China
China Wuhan, China
China Wuxi, China
China Xiamen, China
China Xianyang, China
China Yantai, China
China Yibin, China
China Zhongshan, China
China Zhuzhou, China
China Zigong, China